Wojciechowska M, Wisniewski O W, Pruszynska-Oszmalek E, Krauss H, Sassek M, Leciejewska N, Kolodziejski P, Wilczak M
Department of Mother and Child Health, Poznan University of Medical Sciences, Poznan, Poland.
Faculty of Health Sciences, Calisia University, Kalisz, Poland.
J Physiol Pharmacol. 2022 Oct;73(5). doi: 10.26402/jpp.2022.5.04. Epub 2023 Mar 16.
Hepcidin is a primary regulator of iron metabolism in the human body. By promoting ferroportin degradation, hepcidin reduces intestinal iron absorption and its release from intracellular stores. In the course of pregnancy, gradually declining hepcidin concentrations encourage placental iron transfer, thereby providing the appropriate amount of iron for fetal development. Hence, we aimed to investigate changes in maternal and cord blood hepcidin and iron metabolism parameters in normal-weight (n=17) and obese (n=17) gestating women, as well as gravid women with a history of hypothyroidism following the restoration of euthyroidism (n=17). All blood samples were taken on the day of delivery, and ELISA kits were used for measurements. A significant increase in maternal hepcidin concentration was observed in obese pregnant women, compared to normal-weight controls (29.53±4.20 ng/mL vs. 25.69±5.70 ng/mL; P<0.05). However, only a slight, insignificant tendency for lower hepcidin was noted in the hypothyroid group, compared to the healthy controls (23.10±6.00 ng/mL vs. 25.69±5.70 ng/mL; P=NS). Moreover, decreased maternal free triiodothyronine, triiodothyronine, free thyroxine, and ferritin levels were revealed in the hypothyroid group, compared to the normal-weight individuals (P<0.05). Furthermore, positive correlations between maternal hepcidin and the majority of maternal thyroid hormones were found, with a most potent relation to FT3 (r=0.40; P<0.01). Interestingly, no alterations of thyroid hormones and iron metabolism parameters were noticed in cord blood in any of the subgroups. In summary, pre-pregnancy obesity is associated with elevated maternal hepcidin, albeit no signs of lowered cord blood iron status were shown. Medical history of hypothyroidism following the restoration of euthyroidism does not substantially influence maternal nor cord blood hepcidin concentration, as well as fetal iron homeostasis, even though free thyroid hormone levels correlate with maternal hepcidin.
铁调素是人体铁代谢的主要调节因子。通过促进铁转运蛋白降解,铁调素减少肠道铁吸收及其从细胞内储存库的释放。在孕期,铁调素浓度逐渐下降可促进胎盘铁转运,从而为胎儿发育提供适量的铁。因此,我们旨在研究正常体重(n = 17)和肥胖(n = 17)孕妇以及甲状腺功能减退症恢复至甲状腺功能正常后妊娠的孕妇(n = 17)的母血和脐血中铁调素及铁代谢参数的变化。所有血样均在分娩当天采集,并使用酶联免疫吸附测定试剂盒进行检测。与正常体重对照组相比,肥胖孕妇的母血铁调素浓度显著升高(29.53±4.20 ng/mL对25.69±5.70 ng/mL;P<0.05)。然而,与健康对照组相比,甲状腺功能减退组仅出现铁调素略有降低但无统计学意义的趋势(23.10±6.00 ng/mL对25.69±5.70 ng/mL;P=无显著性差异)。此外,与正常体重个体相比,甲状腺功能减退组母血游离三碘甲状腺原氨酸、三碘甲状腺原氨酸、游离甲状腺素和铁蛋白水平降低(P<0.05)。此外,发现母血铁调素与大多数母血甲状腺激素之间存在正相关,其中与游离三碘甲状腺原氨酸的关系最为显著(r = 0.40;P<0.01)。有趣的是,在任何亚组的脐血中均未发现甲状腺激素和铁代谢参数的改变。总之,孕前肥胖与母血铁调素升高有关,尽管未显示脐血铁状态降低的迹象。甲状腺功能减退症恢复至甲状腺功能正常后的病史对母血和脐血铁调素浓度以及胎儿铁稳态并无实质性影响,尽管游离甲状腺激素水平与母血铁调素相关。